Record citatie

APA (7e ed.) Bronvermelding
F, M., C, M., S, C., F, F., L, P., T, B., . . . M, M. (2024). Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study. Dove Medical Press.
Chicago (17e ed.) Bronvermelding
F, Martora, Marasca C, Cacciapuoti S, Fariello F, Potestio L, Battista T, Scalvenzi M, en Megna M. Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study. Dove Medical Press, 2024.
MLA (9e ed.) Bronvermelding
F, Martora, et al. Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study. Dove Medical Press, 2024.
Let op: Deze citaties zijn niet altijd 100% accuraat.